Page last updated: 2024-08-21

chelidonine and Neoplasms

chelidonine has been researched along with Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L	1
Chen, K; Chen, Z; Meng, Z; Qian, L; Wang, C; Wang, P	1
Apers, S; Capistrano I, R; Gravekamp, C; Lardon, F; Pieters, L; Wouters, A	1

Reviews

1 review(s) available for chelidonine and Neoplasms

Article	Year
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nature cell biology, 2015, Volume: 17, Issue:11 Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction	2015

Article

Year

6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.

Nature cell biology, 2015, Volume: 17, Issue:11

Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction

2015

Other Studies

2 other study(ies) available for chelidonine and Neoplasms

Article	Year
Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 07-01, Volume: 26, Issue:13 Topics: Animals; Apoptosis; Benzophenanthridines; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; GTP Phosphohydrolases; Humans; Membrane Proteins; Mice; Mutation; Neoplasms; Nuclear Proteins; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Xenograft Model Antitumor Assays	2020
In vitro and in vivo investigations on the antitumour activity of Chelidonium majus. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2015, Dec-15, Volume: 22, Issue:14 Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Benzophenanthridines; Berberine Alkaloids; Cell Line, Tumor; Chelidonium; Female; Humans; Inhibitory Concentration 50; Isoquinolines; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms; Pancreatic Neoplasms; Plant Extracts; Plants, Medicinal	2015

Article

Year

Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 07-01, Volume: 26, Issue:13

Topics: Animals; Apoptosis; Benzophenanthridines; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; GTP Phosphohydrolases; Humans; Membrane Proteins; Mice; Mutation; Neoplasms; Nuclear Proteins; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Xenograft Model Antitumor Assays

2020

In vitro and in vivo investigations on the antitumour activity of Chelidonium majus.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2015, Dec-15, Volume: 22, Issue:14

Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Benzophenanthridines; Berberine Alkaloids; Cell Line, Tumor; Chelidonium; Female; Humans; Inhibitory Concentration 50; Isoquinolines; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms; Pancreatic Neoplasms; Plant Extracts; Plants, Medicinal

2015